Navigation Links
Actavis Announces 42% Increase to $2.01 in Second Quarter 2013 Non-GAAP Earnings Per Share
Date:7/25/2013

the Acquisition); the anticipated size of the markets and continued demand for Actavis' and Warner Chilcott's products; the impact of competitive products and pricing; access to available financing (including financing for the Acquisition or refinancing of Actavis or Warner Chilcott debt) on a timely basis and on reasonable terms; maintaining a position in the Standard & Poor's 500; the risks of fluctuations in foreign currency exchange rates; the risks and uncertainties normally incident to the pharmaceutical industry, including product liability claims and the availability of product liability insurance on reasonable terms; the difficulty of predicting the timing or outcome of pending or future litigation or government investigations; periodic dependence on a small number of products for a material source of net revenue or income; variability of trade buying patterns; changes in generally accepted accounting principles; risks that the carrying values of assets may be negatively impacted by future events and circumstances; the timing and success of product launches; the difficulty of predicting the timing or outcome of product development efforts and regulatory agency approvals or actions, if any; costs and efforts to defend or enforce intellectual property rights; difficulties or delays in manufacturing; the availability and pricing of third party sourced products and materials; successful compliance with governmental regulations applicable to Actavis' and Warner Chilcott's manufacturers, facilities, products and/or businesses; changes in the laws and regulations affecting, among other things, pricing and reimbursement of pharmaceutical products; changes in tax laws or interpretations that could increase Actavis' consolidated tax liabilities; the loss of key senior management or scientific staff; and such other risks and uncertainties detailed in Actavis' periodic public filings with the SEC including but not limited to Actavis' Quarterly Report on Form 10-Q
'/>"/>
SOURCE Actavis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related medicine technology :

1. Watson to Acquire Actavis Group for EUR4.25 Billion
2. Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets)
3. Actavis Launches Generic Equivalent of Adalat® CC 90mg (Nifedipine Extended-Release Tablets, USP)
4. Watson and Actavis Receive FTC Second Request
5. Watson Announces New Name -- Actavis -- for Global Operations
6. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
7. Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
8. Actavis, Inc. to Present at the RBC Capital Markets Healthcare Conference
9. Actavis Full Year 2012 Net Revenue Increases 29% to $5.91 Billion
10. Actavis, Inc. to Present at the Cowen & Company 33rd Annual Health Care Conference
11. Actavis, Inc. to Present at the Barclays 2013 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... HAYWARD, Calif. , July 6, 2015  Impax ... Larry Hsu , Ph.D. has resigned from the ... business activities. Dr. Hsu was a co-founder of Impax ... Chief Executive Officer from October 2006 until April 2014. ... Fred Wilkinson , Impax,s President and Chief Executive ...
(Date:7/6/2015)... , July 6, 2015 Akcea Therapeutics, ... ISIS ), announced today that the U.S. ... Designation to volanesorsen (ISIS-APOCIII Rx ) for the ... FCS is a rare genetic disease characterized by ... In a Phase 2 study published in the ...
(Date:7/6/2015)... , July 6, 2015 /PRNewswire/ -- China Nepstar Chain Drugstore ... a leading retail drugstore chain in China ... stores, today announced that its board of directors has ... 2015, from Simin Zhang , chairman of the ... Drugstore Holding Ltd., an investment vehicle wholly owned by ...
Breaking Medicine Technology:Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 2Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 3Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 4Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 5Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 2Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 3Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 5Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 6China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 2China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 3China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 4China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 5China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 6
... Scientific Pte. Ltd today announced that the National University ... in its groundbreaking study: Abdominal Wall Closure After ... of TIGR® Matrix (100% Resorbable) ... received DSRB approval on 9th September 2010. There are ...
... PennDOT and the Pennsylvania State Police are reminding motorists ... over-the-counter medication can be just as dangerous as driving ... PennDOT will work with state and municipal ... enforcement, with increased emphasis on driving under the influence ...
Cached Medicine Technology:National University Hospital Singapore Operates on Asia's 1st TRAM Flap Patient Using TIGR® Matrix Surgical Mesh, the World's 1st Long-Term Resorbable Mesh 2National University Hospital Singapore Operates on Asia's 1st TRAM Flap Patient Using TIGR® Matrix Surgical Mesh, the World's 1st Long-Term Resorbable Mesh 3PennDOT, State Police Caution Motorists About Dangers of Driving Under Influence of Legal Drugs 2
(Date:7/6/2015)... Connecticut (PRWEB) , ... July 06, 2015 , ... ... Medical Practice & Medical Spa industries, announces the return of its complimentary educational ... Acara team of aesthetic medical business leaders creates success for their clients through ...
(Date:7/6/2015)... ... July 06, 2015 , ... Olive Fertility Centre is proud to ... Graduate Teaching Award on behalf of the department of Family Practice. , “This award ... to be practicing in. The technology is changing so rapidly and we are also ...
(Date:7/6/2015)... ... July 06, 2015 , ... Cancer Hope Network (CHN) has ... medical professionals to chat with the CHN patient services team and connect with ... diagnosis is often the most traumatic experience of a person’s life,” said CHN ...
(Date:7/6/2015)... Cutler Bay, Florida (PRWEB) , ... July 06, 2015 , ... ... 22nd facility on Monday, July 6. The newly constructed urgent care center will serve ... medical services. , In addition to being MD Now’s 22nd South Florida location, the ...
(Date:7/6/2015)... ... 2015 , ... World renowned Los Angeles facial plastic surgeon , Dr. ... comprehensive treatment solutions. Individuals that want to make multiple changes to their facial appearance ... resolves each of their needs. , "Anytime I see an opportunity to change ...
Breaking Medicine News(10 mins):Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 2Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 3Health News:Olive Fertility Centre Physician Honoured for Teaching 2Health News:Cancer Hope Network Launches Upgraded Website to Support Cancer Patients, Caregivers 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 3Health News:Los Angeles Plastic Surgeon, Dr. Paul Nassif, is Now Offering Comprehensive Facial Plastic Surgery Procedures 2
... June 28 Western Growers is,urging the House Committee ... the salmonella outbreak that has been associated with fresh,red ... have been unable to definitively determine the source or,the ... a "mystery,",tomato growers across the nation are suffering irreparable ...
... and Personal Care product line by Birchwood Laboratories ... anal incontinence and for everyday personal care. Designed ... vaginal, and perineal cleanliness while relieving irritation to ... decrease anxiety while improving quality of life for ...
... WHITEHOUSE STATION, N.J., June 27 /PRNewswire-FirstCall/,-- Schering-Plough Corp. ... Inc. (NYSE: MRK ),announce the withdrawal of ... tablet., The companies also terminated the Schering-Plough/Merck ... 2000 to develop and,market a fixed-combination product that ...
... Estonia and COPENHAGEN, June 27 , - New ... Ministers of health from 53 countries (1), which make ... health systems, committing themselves,to concrete and measurable action on ... and the international community to hold them to,account., ...
... - Accelera Recognised as Key Partner in the Development ... the treatment of African,trypanosomiasis, commonly known as "sleeping sickness", ... a business unit of,Nerviano Medical Sciences (NMS), is to ... Year. The award will be conferred today in New ...
... Replikins Ltd. has found that H5N1 virus replikin peak ... Vietnam and Israel indicate that a new replikin cycle ... of the previous cycle identified by the company. Although ... increase in replikin count, a feature of each of ...
Cached Medicine News:Health News:Western Growers Asks for Congressional AG Committee Hearings Regarding Salmonella Outbreak and Investigations 2Health News:Birchwood Laboratories Expands B-SURE™ Incontinence and Personal Care Product Line™; Three New Products Added Including B-SURE Fresh 'n Go™, B-SURE Bottom Balm™ and B-SURE Traveler™ 2Health News:European Ministers Sign Groundbreaking Charter on Health System 2Health News:European Ministers Sign Groundbreaking Charter on Health System 3Health News:The "DNDi Project of the Year": The Development of Fexinidazole to Treat "Sleeping Sickness" 2Health News:H5N1 Virus Replikin Gene Counts Indicate a New More Virulent Influenza Cycle Has Begun 2
... determination of Ang II is ... the pharmacological effect and efficiency ... angiotensin converting enzyme inhibitors (ACE ... antagonists as well as for ...
... antigen test is a visual ... presumptive qualitative detection of Respitory ... specimens in neonatal and pediatric ... test has a built-in procedural ...
Rapid Immunoassay for the detection of Respiratory Syncytial Virus....
... BD Directigen EZ RSV Test utilizes a new, ... one device for rapid RSV detection. The testing ... method whereby dried reagents have already been applied ... a two-step process, with clear-cut results shown by ...
Medicine Products: